(Q33374053)

English

A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome

scientific article

Statements

A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome (English)
30 January 2007
4158-4163

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit